Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Oncopeptides AB

OND
Current price
0.17 EUR +0.0016 EUR (+0.95%)
Last closed 2.11 SEK
ISIN SE0009414576
Sector Healthcare
Industry Biotechnology
Exchange Frankfurt Exchange
Capitalization 469 403 741 SEK
Yield for 12 month -63.04 %
1Y
3Y
5Y
10Y
15Y
OND
21.11.2021 - 28.11.2021

Oncopeptides AB (publ), a biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally. Its lead product candidate is Pepaxti (melflufen), a drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. The company also engages in the research for small popypeptide based killer engages for the treatment of RRMM and hematological or solid tumors; and other peptide-drug conjugates for glioblastoma and hematological or solid tumors. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden Address: Luntmakargatan 46, Stockholm, Sweden, 111 37

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

60.44 SEK

P/E ratio

Dividend Yield

Current Year

+35 249 865 SEK

Last Year

+8 362 081 SEK

Current Quarter

+8 161 912 SEK

Last Quarter

+5 076 300 SEK

Current Year

+36 329 780 SEK

Last Year

+8 356 078 SEK

Current Quarter

+7 214 107 SEK

Last Quarter

+4 789 061 SEK

Key Figures OND

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -254 092 252 SEK
Operating Margin TTM -898.23 %
PE Ratio
Return On Assets TTM -39.64 %
PEG Ratio
Return On Equity TTM -141.97 %
Wall Street Target Price 60.44 SEK
Revenue TTM 21 387 118 SEK
Book Value 0.9 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -68.6 %
Dividend Yield
Gross Profit TTM 8 356 079 SEK
Earnings per share -1.72 SEK
Diluted Eps TTM -1.72 SEK
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics OND

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History OND

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 3574:2547
Payout Ratio
Last Split Date 16.04.2024
Dividend Date

Stock Valuation OND

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 9.2894
Price Sales TTM 21.948
Enterprise Value EBITDA -1.549
Price Book MRQ 2.5236

Financials OND

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators OND

For 52 weeks

2 SEK 9.41 SEK
50 Day MA 2.35 SEK
Shares Short Prior Month
200 Day MA 4.6 SEK
Short Ratio
Shares Short
Short Percent